Older Coverage
stories 541–600 of 633
IPOS-1 filed, ticker SYTN
Intel-Backed Edge AI Chipmaker Syntiant Files for IPO
Syntiant, an Intel-backed maker of ultra-low-power AI chips for earbuds and cars with over 100 million units deployed, filed for a Nasdaq IPO under ticker SYTN after posting a $20.9 million Q1 net loss on $64.5 million revenue.
Government Cybersecurity Firm Cycurion Files for Nasdaq IPO
IPOS-1 filed, ticker CYCU
Government Cybersecurity Firm Cycurion Files for Nasdaq IPO
Cycurion, which sells AI-driven cybersecurity to the Department of Defense and Homeland Security with an $80 million backlog, filed for a Nasdaq IPO under ticker CYCU after closing a bolt-on Secuvant acquisition.
Agility's SPAC Bet: Can Real Robots Beat SPAC Volatility?
IPO$2.5B SPAC deal, largest in sector
Agility's SPAC Bet: Can Real Robots Beat SPAC Volatility?
Agility Robotics' $2.5B SPAC merger tests whether a humanoid robotics company with real warehouse revenue can avoid the boom-bust volatility that has plagued most SPAC-listed companies over the past several cycles.
Humanoid Robotics Firm Agility Goes Public via $2.5B SPAC
IPO~$2.5B valuation, $620M+ raise
Humanoid Robotics Firm Agility Goes Public via $2.5B SPAC
Agility Robotics is merging with Churchill Capital Corp XI in the largest capital raise in humanoid robotics history, with $300M+ in booked revenue but a CEO who says home robots are still a decade away.
Agility Robotics Takes the SPAC Route to a $2.5B IPO
IPO$2.5B valuation / $620M+ raised
Agility Robotics Takes the SPAC Route to a $2.5B IPO
Agility Robotics is going public via SPAC merger at a ~$2.5B valuation, becoming the first pure-play humanoid robotics company to trade publicly, even as its CEO says home robots are a decade away.
Europe's Late-Summer IPO Pipeline Is Filling Up Fast
IPO2 European listings in one week
Europe's Late-Summer IPO Pipeline Is Filling Up Fast
Swiss healthcare REIT Infracore and German defense-communications firm Smag are both racing toward July listings, adding to a busier-than-expected European IPO calendar even as broader international indices soften.
Anthropic's IPO Math Now Implies a Trillion-Dollar Debut
IPO$1.05T-$1.15T implied valuation
Anthropic's IPO Math Now Implies a Trillion-Dollar Debut
Secondary markets are pricing Anthropic's confidential IPO filing at $1.05-$1.15 trillion, a premium over its last private round, as revenue growth accelerates ahead of an October Nasdaq target.
SK Hynix Nears the Biggest ADR Listing Ever
IPO~$29.4B targeted raise
SK Hynix Nears the Biggest ADR Listing Ever
SK Hynix is on track for a tentative July 10 Nasdaq debut targeting roughly $29 billion, which would surpass Alibaba's 2014 New York listing as the largest ADR offering in market history.
Why 2026's Marquee AI IPOs Keep Slipping to 2027
IPOPotential delay to 2027
Why 2026's Marquee AI IPOs Keep Slipping to 2027
OpenAI is reportedly weighing a delay of its IPO to 2027 amid volatile public markets and SpaceX's choppy post-debut trading, a hesitation that could reshape the entire 2026-2027 tech IPO pipeline.
Small-Cap Tech IPOs Are Having a Quiet Moment in 2026
IPOIPO count +7.95% YoY
Small-Cap Tech IPOs Are Having a Quiet Moment in 2026
Beyond the SpaceX and Bending Spoons headlines, 2026's tech IPO count is already running about 8% ahead of 2025, with smaller healthcare-data and industrial-tech filers like OneMedNet quietly testing the market.
IPO Market Breadth Slips as AI Jitters Spread Abroad
IPO82 IPOs priced in 2026 YTD
IPO Market Breadth Slips as AI Jitters Spread Abroad
International IPO indices softened this week even as US listings stayed active, with new SPAC filings targeting AI, quantum computing and Asia-focused deals showing the pipeline still building beneath the volatility.
SpaceX Set to Join Nasdaq-100, Unlocking ~$4.3B in Fund Buying
IPO~$7.3B combined passive inflows
SpaceX Set to Join Nasdaq-100, Unlocking ~$4.3B in Fund Buying
SpaceX will join the Nasdaq-100 before market open on July 7, just 17 days after its June IPO -- one of the fastest index inclusions on record -- forcing an estimated $4.3B in passive index-fund buying.
IQM, Europe's First Public Quantum Company, Admits the Future of the Tech Is
IPO~$1.9B valuation
IQM, Europe's First Public Quantum Company, Admits the Future of the Tech Is
IQM, the Finland-based full-stack quantum computing company, went public on Nasdaq July 2 via a SPAC merger with RAAQ at a roughly $1.9 billion valuation, but shares traded below the IPO price for most of the day -- a lukewarm debut IQM's own prospectus.
Jersey Mike's IPO Filing Shows Just How Far AI Buzzwords Have Spread
IPOS-1 filed
Jersey Mike's IPO Filing Shows Just How Far AI Buzzwords Have Spread
Jersey Mike's Subs Inc. filed its S-1 for an IPO on July 2, mentioning 'artificial intelligence' or 'AI' 22 times despite being a sandwich-chain franchisor with no AI product offerings, TechCrunch reported the same day.
Travel App Hopper to Pay $35M in FTC Settlement Over 'Unfairly' Charging Hidden Fees
IPO$35M settlement
Travel App Hopper to Pay $35M in FTC Settlement Over 'Unfairly' Charging Hidden Fees
Hopper agreed to pay $35 million to settle FTC allegations that it used deceptive 'dark patterns' to hide fees and misrepresent the costs and benefits of its 'VIP Support' and 'Price Freeze' services, the agency announced July 2. The settlement follows a pattern of recent FTC crackdowns on hidden-fee practices at Match, StubHub, neobank Dave and Fortnite, and requires Hopper to clearly disclose all fees going forward, though the company says the practices at issue were discontinued in mid-2023, before the FTC's inquiry began.
Scribe Therapeutics, Co-Founded by Nobel Laureate Jennifer Doudna, Files S-1 for Nasdaq IPO
IPOS-1 filed
Scribe Therapeutics, Co-Founded by Nobel Laureate Jennifer Doudna, Files S-1 for Nasdaq IPO
Scribe Therapeutics filed its S-1 with the SEC on July 2, seeking to list on the Nasdaq Global Market under the ticker 'SCTX.' The clinical-stage biotech, co-founded by CRISPR pioneer and Nobel laureate Dr. Jennifer Doudna, has raised roughly $150 million in equity financing since 2017 and is advancing STX-1150 -- an epigenetic-silencing CRISPR candidate for cardiovascular disease -- through an Australian first-in-human trial, while disclosing only $49.7 million in cash and marketable securities against a $175.1 million accumulated deficit.
Cycurion Files S-1 as AI Cybersecurity Firm Completes Secuvant Merger
IPO~25.9M shares registered for resale
Cycurion Files S-1 as AI Cybersecurity Firm Completes Secuvant Merger
Cycurion, a McLean, Virginia-based AI-driven IT cybersecurity and public-sector technology firm, filed a Form S-1 covering nearly 26 million shares for resale, following its completed merger with security services firm Secuvant, which closed June 3, 2026.
Peraso Files S-1 for a $25M Equity Line as the mmWave Chipmaker's Stock Sits Under $1
IPOUp to $25M equity line
Peraso Files S-1 for a $25M Equity Line as the mmWave Chipmaker's Stock Sits Under $1
Peraso Inc., a fabless semiconductor company building millimeter-wave (mmWave) wireless chips, filed an S-1 on July 2 registering up to 31.75 million shares for resale by Roth Principal Investments under a new Common Stock Purchase Agreement dated June 30 -- an equity line that could provide Peraso up to $25 million in gross proceeds. The filing comes with shares trading at just $0.83 on the Nasdaq Capital Market as of June 29, and Peraso's auditor has flagged substantial doubt about its ability to continue as a going concern.
Bending Spoons' Rocky First Week: 40% Pop, Then an 8.5% Slide
IPO$1.68B raised / ~$25B cap
Bending Spoons' Rocky First Week: 40% Pop, Then an 8.5% Slide
Bending Spoons surged 40% on its Nasdaq debut in the largest software IPO of 2026, then gave back 8.5% the next trading day, underscoring how volatile even a successful AI-era IPO's first week can be.
IPOs and M&A Soared to a Record $113B in Q2 2026 as the AI Boom Reshapes Exits
IPO$113B in $1B+ M&A (record quarter)
IPOs and M&A Soared to a Record $113B in Q2 2026 as the AI Boom Reshapes Exits
Crunchbase News reported July 2 that 32 companies went public above a $1 billion valuation in Q2 2026 and 24 more were acquired at $1 billion-plus valuations totaling a record $113 billion, headlined by SpaceX's $1.77 trillion IPO (raising $75 billion) and.
Scribe Therapeutics Files for $75M IPO to Test Early-Stage Biotech Appetite
IPOUp to $75M IPO
Scribe Therapeutics Files for $75M IPO to Test Early-Stage Biotech Appetite
Scribe Therapeutics filed to raise up to $75 million in a Nasdaq IPO, becoming an early test of public-market appetite for Phase 1 biotechs -- its lead candidate, a CRISPR-based epigenetic therapy targeting PCSK9 to lower LDL cholesterol, is already in a.
Uber-Backed Lime Prices IPO at $25, Pops on Nasdaq Debut After Years of Delay
IPO$174M IPO, +9% debut
Uber-Backed Lime Prices IPO at $25, Pops on Nasdaq Debut After Years of Delay
Lime, the Uber-backed scooter and e-bike rental company, priced its Nasdaq IPO at $25 per share on June 30 — the midpoint of its $24-$26 range — selling 6.96 million shares to raise $174 million at a $1.6 billion valuation. Shares jumped about 9% in their first hour of trading July 1 under ticker LIME, capping years of on-again, off-again public-listing speculation for the micromobility company.
Bending Spoons Defies the SaaS Slump, Surges 40% on IPO Day to a $25.7B
IPO$25.7B market cap (+40% day one)
Bending Spoons Defies the SaaS Slump, Surges 40% on IPO Day to a $25.7B
Milan-based Bending Spoons priced its IPO at $29 per share, raised $1.68 billion, and closed its first trading day up 40% at $40.50, pushing its market cap to $25.7 billion -- more than double its prior $11 billion private valuation -- TechCrunch reported.
Bending Spoons Defies the SaaS Slump, Surges 40% on Nasdaq Debut to a Near-$26B Close
IPO$1.68B raised, +40% debut
Bending Spoons Defies the SaaS Slump, Surges 40% on Nasdaq Debut to a Near-$26B Close
Bending Spoons priced its Nasdaq IPO at $29 per share on June 30 — above its $26-$28 marketed range — raising $1.68 billion at an $18.4 billion valuation, then closed its first trading day up roughly 40% near $25.7 billion. The Milan-based company, which buys and revitalizes aging tech brands including AOL, Evernote, Meetup and Vimeo, posted $601 million in Q1 revenue and swung to a $27.4 million profit from a $112 million loss a year earlier.
VenHub Global Files Amended S-1 for Nasdaq Direct Listing of Fully Autonomous Robotic Stores
IPODirect listing, no new capital
VenHub Global Files Amended S-1 for Nasdaq Direct Listing of Fully Autonomous Robotic Stores
VenHub Global filed an S-1/A amendment on July 1 as it works toward a direct listing on Nasdaq under ticker VNHB, registering up to 15.5 million shares for sale by existing holders rather than raising new capital. The company builds fully autonomous, AI-driven robotic smart stores, has deployed three to date, and carries an accumulated deficit near $98.8 million with auditors flagging substantial going-concern doubt.
Bending Spoons Surges 40% on Nasdaq Debut After $18.4B IPO Priced Above Range
IPO$1.68B IPO, shares +40%
Bending Spoons Surges 40% on Nasdaq Debut After $18.4B IPO Priced Above Range
Milan-based Bending Spoons priced its Nasdaq IPO at $29 a share on June 30 — above its marketed $26-$28 range — raising $1.68 billion and valuing the company at roughly $18.4 billion. Shares opened at $31 on July 1, touched an intraday high of $42.50, and closed the session at $40.50, up nearly 40%, making it one of the strongest software IPO debuts of 2026 despite a broader SaaS slowdown.
Micromobility Leader Lime Debuts on Nasdaq
IPO$24-$26/share, ~$167M-$181M raise
Micromobility Leader Lime Debuts on Nasdaq
Shared e-bike and scooter operator Lime listed on Nasdaq on July 1, pricing nearly 7 million shares between $24 and $26, becoming one of the first profitable consumer mobility names to test public markets in 2026.
OneMedNet Files S-1 to Register Shares Under $8.5M Standby Equity Purchase Agreement
IPOUp to 11.68M shares
OneMedNet Files S-1 to Register Shares Under $8.5M Standby Equity Purchase Agreement
OneMedNet Corporation, a Minnesota-based healthcare data company, filed a Form S-1 on July 1 registering up to 11.68 million shares of common stock, including up to 8.5 million shares issuable under a Standby Equity Purchase Agreement (SEPA) dated the same day. SEPAs let a public company draw down capital incrementally by selling shares to an investor at its own discretion, a financing structure often used by smaller-cap companies that need flexible access to capital without a traditional follow-on offering.
Actelis Networks Files Fresh S-1 as Hybrid Fiber-Copper Networking Firm Deepens Its Public Listing
IPOS-1 filed
Actelis Networks Files Fresh S-1 as Hybrid Fiber-Copper Networking Firm Deepens Its Public Listing
Actelis Networks filed a new Form S-1 with the SEC on July 1, following an earlier registration statement that went effective in November 2025. The Sunnyvale, California-based company sells hybrid fiber-copper-coax networking equipment for IoT, security and telecom deployments, letting customers deploy fast, secure connectivity over existing copper and coaxial infrastructure without a full fiber rebuild.
Asia AI Group Files Fresh S-1, Widening the AI-Branded IPO Pipeline Beyond the Frontier Labs
IPOS-1 filed
Asia AI Group Files Fresh S-1, Widening the AI-Branded IPO Pipeline Beyond the Frontier Labs
Asia AI Group Inc filed a Form S-1 with the SEC on July 1, joining a wave of smaller companies filing AI-branded registration statements even as OpenAI, Anthropic and SpaceX dominate IPO headlines with valuations near or above $1 trillion. The filing adds to a growing list of small-cap AI-named S-1s this year, underscoring how far the AI-IPO enthusiasm has spread beyond the handful of marquee frontier labs getting most investor attention.
Freedom Metals Acquisition Corp Amends S-1 for Critical-Metals-Focused SPAC IPO
IPOSPAC IPO filing
Freedom Metals Acquisition Corp Amends S-1 for Critical-Metals-Focused SPAC IPO
Freedom Metals Acquisition Corp filed an S-1/A amendment on July 1, detailing a blank-check company structure targeting acquisitions in the critical metals and mining sector. Sponsor NLC America SPAC 1 LLC and underwriter Cohen & Company Capital Markets have committed to purchase private placement units worth up to roughly $9.1 million if the over-allotment option is exercised in full, positioning the SPAC to hunt for a target in a sector newly critical to both AI data-center buildouts and defense supply chains.
Lime Rings the Nasdaq Bell at $25 as Uber-Backed Scooter Giant Reaches $1.8B Market Cap
IPO$174M IPO at $1.8B
Lime Rings the Nasdaq Bell at $25 as Uber-Backed Scooter Giant Reaches $1.8B Market Cap
Lime — the world's largest shared micromobility operator, formally Neutron Holdings — priced its Nasdaq IPO at the $25 midpoint on June 30 and begins trading July 1 under ticker LIME, raising roughly $174-182M at a $1.63-1.8B market cap. Uber, which owns a meaningful stake and operates Lime bikes and scooters through its ride-hail app, is a key backer testing whether the scooter category still has a public-market future after Bird's bankruptcy.
QumulusAI Files S-1/A for Nasdaq Direct Listing as GPU-Cloud Provider to Underserved AI Customers
IPODirect listing filed
QumulusAI Files S-1/A for Nasdaq Direct Listing as GPU-Cloud Provider to Underserved AI Customers
QumulusAI filed a seventh S-1/A amendment on July 1 ahead of a planned Nasdaq direct listing, detailing an Atlanta-based GPU-as-a-service business built from the 2022 merger of a blockchain-hosting company and a data-center asset firm, later rebranded after acquiring The Cloud Minders in 2025. The company reported $3.4 million in quarterly revenue against a $5.5 million operating loss, is scaling toward 120 megawatts and up to 90,000 Nvidia B200/B300 GPUs, and disclosed going-concern risk in its filing.
Encore Medical Files Amended S-1 to Fund US Trials for Its Heart-Defect Closure Device
IPO~$12.6M-$14.67M
Encore Medical Files Amended S-1 to Fund US Trials for Its Heart-Defect Closure Device
Encore Medical filed an amended S-1 on July 1 ahead of a planned NYSE American listing under ticker EMI, offering 3 million shares at an expected $5.00 each to raise roughly $12.6-14.67 million to fund US clinical trials for its catheter-delivered heart-defect closure device, which has completed more than 35,000 implants outside the United States but has not yet been approved for US sale. Underwriters BofA Securities, Goldman Sachs and Morgan Stanley are jointly leading the offering.
Already-Public Actelis Networks Files New S-1 to Amend Its Equity Line With White Lion Capital
IPOUp to 15.85M shares
Already-Public Actelis Networks Files New S-1 to Amend Its Equity Line With White Lion Capital
Actelis Networks, the Nasdaq-listed hybrid fiber-coax networking company, filed a Form S-1 on July 1 to re-register shares tied to an amended equity line of credit (ELOC) with White Lion Capital, after 10 million of the 10.6 million shares originally registered for the arrangement in October 2025 remained unsold. The amendment registers up to 15.85 million shares across revised ELOC shares, commitment shares and warrant shares — a dilutive financing structure for a cybersecurity-hardened networking equipment maker, rather than a new IPO.
Solid-State Battery Maker Factorial Energy Lists on Nasdaq at $1.3B via SPAC Merger
IPO$1.3B equity value
Solid-State Battery Maker Factorial Energy Lists on Nasdaq at $1.3B via SPAC Merger
Factorial Energy completed its business combination with Cartesian Growth Corporation III and began trading on Nasdaq under ticker FAC on June 8, implying about $1.3 billion in equity value and delivering over $100 million in gross proceeds to fund commercialization of its solid-state batteries for defense, data centers, drones, robotics and e-mobility. Stellantis holds a 9.5% stake in the combined company, underscoring continued automaker conviction in solid-state battery technology.
Encore Medical Prices Structural Heart IPO at $5/Share on NYSE American as Cash Runway Tightens
IPO$5.00/share IPO
Encore Medical Prices Structural Heart IPO at $5/Share on NYSE American as Cash Runway Tightens
Encore Medical, a structural heart device company developing transcatheter septal occlusion products, filed its latest S-1/A on June 30, targeting an IPO of 3 million shares at an expected $5 per share on NYSE American under ticker EMI. The company's cash balance stood at just $34,619 as of March 31, 2026, underscoring how urgently it needs the offering to fund ongoing US clinical trials.
SeeQC Files S-1 for Nasdaq IPO to Fund Digital Quantum Computing Chips
IPO~$1B valuation
SeeQC Files S-1 for Nasdaq IPO to Fund Digital Quantum Computing Chips
SeeQC, which builds digital quantum-computing infrastructure, filed a Form S-1 to list on the Nasdaq Global Market under ticker 'SEQC,' paired with a $65 million PIPE financing that values the combined entity at roughly $1 billion. The company integrates superconducting single-flux-quantum logic with cryogenic CMOS to shrink the wiring and heat load of quantum systems -- reporting $4.2 million in 2025 revenue against a $12.2 million net loss.
SunPower Files S-1 as Reborn Residential Solar Company Eyes Public Markets
IPOS-1 filed
SunPower Files S-1 as Reborn Residential Solar Company Eyes Public Markets
SunPower filed a Form S-1 with the SEC on June 29, registering shares for resale as the rebuilt residential and small-business solar company steps toward the public markets. Trading under ticker SPWR, the company is pitching an end-to-end offering -- technology platform, financing and high-performance equipment -- in a U.S. solar market reshaped by shifting incentives and consolidation.
SeeQC Files S-1 as Quantum Computing IPO Wave Widens Beyond IonQ and D-Wave
IPOS-1 filed
SeeQC Files S-1 as Quantum Computing IPO Wave Widens Beyond IonQ and D-Wave
Digital quantum computing firm SeeQC filed an S-1 on June 29, becoming one of the first pure-play quantum specialists to file since the 2021 SPAC rush. SeeQC's superconducting chips integrate quantum bits directly with classical control electronics, targeting scalable systems that competitors say require room-scale cabinets today.
Spine-Surgery Device Maker Tenon Medical Files to Raise Fresh Capital
IPOS-1MEF filed
Spine-Surgery Device Maker Tenon Medical Files to Raise Fresh Capital
Tenon Medical filed an S-1MEF with the SEC on June 29, registering additional shares to support a public offering as the small-cap medical-device company funds the commercialization of its sacroiliac (SI) joint fusion system. The filing is a window into the steady, less-glamorous flow of medtech issuers tapping public markets even as AI and mega-IPOs dominate headlines.
Q2 2026 Delivers the Most Billion-Dollar Startup Exits Since the 2021 Peak
IPOMost $1B+ exits since 2021
Q2 2026 Delivers the Most Billion-Dollar Startup Exits Since the 2021 Peak
Startup exits worth $1 billion or more were more numerous in Q2 2026 than at any point since the 2021 market peak, according to Crunchbase data -- powered by SpaceX's record IPO (a $2.1 trillion first-day market cap on $75 billion raised), Cerebras's and Quantinuum's debuts, and SpaceX's $60 billion acquisition of Cursor. The quarter signals the long-frozen exit window has decisively reopened for late-stage tech.
Drone-Delivery Pioneer Matternet Files an S-1 to Register Shares After Going Public
IPOS-1 filed
Drone-Delivery Pioneer Matternet Files an S-1 to Register Shares After Going Public
Matternet, which bills itself as the world's only FAA type-certified drone-delivery platform, filed a Form S-1 with the SEC, following its May 2026 reverse-merger debut and a ~$33 million private placement. The filing registers shares as the company funds the rollout of its next-generation delivery platform across food, retail and healthcare -- a marker of how the autonomy IPO pipeline is broadening beyond ground robotaxis.
Crunchbase: Q2 2026 Delivered the Most Billion-Dollar Startup Exits Since the 2021 Peak
IPOMost exits since 2021
Crunchbase: Q2 2026 Delivered the Most Billion-Dollar Startup Exits Since the 2021 Peak
Crunchbase data published June 29 shows venture-backed startup exits valued at $1 billion or more hit their highest count in Q2 2026 since the 2021 market peak, headlined by SpaceX's roughly $2.1 trillion first-day market cap IPO and SpaceX's subsequent $60 billion all-stock acquisition of Cursor — the priciest purchase of a private, venture-backed startup ever, nearly double Google's $32 billion Wiz deal.
Consumer Brand House AMASS Brands Files S-1, Testing the CPG IPO Window
IPOS-1 filed
Consumer Brand House AMASS Brands Files S-1, Testing the CPG IPO Window
AMASS Brands filed a Form S-1 with the SEC on June 29, stepping toward a public listing as a consumer-brands company -- a notable test of whether the reopened IPO window extends beyond AI and deep tech into consumer packaged goods. The filing adds a different flavor to a 2026 pipeline dominated by frontier-tech and infrastructure names.
Autonomous Industrial Drone Firm Exyn Technologies Files S-1 Amid Defense-Tech IPO Rush
IPOS-1 filed
Autonomous Industrial Drone Firm Exyn Technologies Files S-1 Amid Defense-Tech IPO Rush
Exyn Technologies filed an S-1 on June 29 to go public, joining a wave of autonomy and defense-tech companies pursuing 2026 IPOs. Its GPS-denied drone autonomy stack ships into mining, industrial inspection and defense customers — a category directly benefiting from Pentagon's Iran-war-accelerated drone procurement push.
Autonomous-Drone Maker Exyn Technologies Files S-1 as Physical AI Heads to Market
IPOS-1 filed
Autonomous-Drone Maker Exyn Technologies Files S-1 as Physical AI Heads to Market
Exyn Technologies, which builds fully autonomous aerial robots for GPS-denied environments like underground mines, filed a Form S-1 with the SEC. The company's drones have achieved Level 4 autonomy -- the highest aerial autonomy demonstrated to date, with onboard mapping and no human pilot -- positioning Exyn in the fast-emerging 'physical AI' category just as governments and investors pour capital into embodied robotics.
Q2 2026 Delivered the Most Billion-Dollar Startup Exits Since 2021
IPOMost exits since 2021
Q2 2026 Delivered the Most Billion-Dollar Startup Exits Since 2021
Q2 2026 produced the most billion-dollar startup exits since the 2021 boom, led by SpaceX's blockbuster IPO and its record $60 billion purchase of Cursor parent Anysphere, according to Crunchbase data. While exit counts still trail the 2021 peak, the sheer size of deals -- with Anthropic and OpenAI now filing to test the trillion-dollar mark -- is the defining feature of the reopened liquidity window.
Classover Rebrands as KIDZ AI and Files S-1 to Fund AI Learning and Compute Push
IPOS-1 filed
Classover Rebrands as KIDZ AI and Files S-1 to Fund AI Learning and Compute Push
KIDZ AI Inc. (Nasdaq: KIDZ), the AI-education company formerly known as Classover Holdings, filed a Form S-1 with the SEC as it pivots from live online enrichment classes for kids toward AI-powered learning systems -- and, notably, AI compute infrastructure and GPU cloud. The rebrand-and-refile captures both the edtech-AI wave and the 2026 trend of small caps chasing the AI-infrastructure story.
Ionic Digital Files S-1 for Nasdaq Listing as Bitcoin-Mining IPOs Return with a Vengeance
IPOS-1 filed
Ionic Digital Files S-1 for Nasdaq Listing as Bitcoin-Mining IPOs Return with a Vengeance
Ionic Digital filed a Form S-1 on June 26 to list on Nasdaq, joining a fresh wave of bitcoin-mining IPOs riding a record-high BTC price and post-halving miner economics. The company operates data-center-scale hosted mining infrastructure and is pivoting portions of capacity toward AI compute contracts.
TEN Holdings Prices a $7.5M Offering via S-1MEF as Micro-Cap Issuance Stirs
IPO$7.5M offering
TEN Holdings Prices a $7.5M Offering via S-1MEF as Micro-Cap Issuance Stirs
TEN Holdings (Nasdaq: XHLD), the parent of event production and broadcasting firm Ten Events, filed an S-1MEF with the SEC and priced a $7.5 million offering of 7.5 million shares at $1.00 each, with WestPark Capital as sole placement agent. The deal is a small but telling sign that capital-markets activity is reaching well down the cap-size spectrum, not just the marquee AI and biotech names.
Jupiter Neurosciences Files S-1 to Fund Its Neuroinflammation and Longevity Pipeline
IPOS-1 filed
Jupiter Neurosciences Files S-1 to Fund Its Neuroinflammation and Longevity Pipeline
Clinical-stage biotech Jupiter Neurosciences (Nasdaq: JUNS) filed a Form S-1 with the SEC to register fresh capital as it advances its lead candidate JOTROL, a proprietary resveratrol platform targeting rare and neuroinflammatory CNS disorders and, increasingly, longevity. The filing adds another central-nervous-system name to a 2026 biotech pipeline that keeps widening alongside AI and chips.
QumulusAI Amends S-1 Again as GPU-Cloud Provider for Underserved Mid-Market AI Teams Nears Nasdaq Debut
IPOS-1/A filed
QumulusAI Amends S-1 Again as GPU-Cloud Provider for Underserved Mid-Market AI Teams Nears Nasdaq Debut
QumulusAI filed its latest S-1/A amendment with the SEC on June 26, continuing a string of amendments dating back to February as it works toward a Nasdaq listing. The company delivers rapid-deployment, GPU-powered cloud infrastructure targeted at small and mid-market AI teams — machine learning groups, AI infrastructure startups and research institutions — that large hyperscalers often underserve or price out.
Akari Therapeutics Files an S-1/A to Fund Its TROP2 Cancer Drug Toward the Clinic
IPOS-1/A filed
Akari Therapeutics Files an S-1/A to Fund Its TROP2 Cancer Drug Toward the Clinic
Oncology biotech Akari Therapeutics (Nasdaq: AKTX) filed a Form S-1/A with the SEC to register capital as it advances AKTX-101, a TROP2-targeting antibody-drug conjugate built on its proprietary PH1 payload platform. The filing adds another clinical-stage cancer name to a 2026 capital-markets pipeline that biotech is increasingly populating alongside AI and chips.
Jupiter Neurosciences Files an S-1 as It Pushes JOTROL Into Parkinson's Trials
IPOS-1 filed
Jupiter Neurosciences Files an S-1 as It Pushes JOTROL Into Parkinson's Trials
Clinical-stage biotech Jupiter Neurosciences (Nasdaq: JUNS) filed a Form S-1 with the SEC to register additional capital as it advances JOTROL, its enhanced resveratrol formulation, into a Phase 2a Parkinson's disease trial. The filing adds a CNS-focused name to a 2026 capital-markets pipeline that biotech is increasingly populating alongside AI and chips.
SpaceX's $60B Cursor Deal Puts the US on Track for a Record Startup M&A Year
IPO$119.8B+ YTD
SpaceX's $60B Cursor Deal Puts the US on Track for a Record Startup M&A Year
Acquirers have spent at least $119.8 billion buying US startups so far in 2026, on pace to beat 2025's record, with SpaceX's $60 billion purchase of Cursor parent Anysphere -- the largest startup acquisition ever -- leading the charge. Biotech made up half the top-10 deals, signaling that the exit window has reopened broadly, not just for AI.
GPS-Monitoring Tech Firm Track Group Files a Form S-1 With the SEC
IPOS-1 filed
GPS-Monitoring Tech Firm Track Group Files a Form S-1 With the SEC
Track Group, which designs location-tracking devices and the software and analytics behind them, filed a Form S-1 with the SEC. The filing adds a govtech and public-safety hardware name to a 2026 IPO pipeline dominated by AI labs and semiconductors -- a reminder that the listing window is broadening to less glamorous, cash-generating niches.
Energy-Midstream Operator Vivakor Files an Amended S-1 Amid Crude Volatility
IPOS-1/A filed
Energy-Midstream Operator Vivakor Files an Amended S-1 Amid Crude Volatility
Vivakor, a Nasdaq-listed integrated energy transportation, storage and crude-logistics operator, filed an amended Form S-1 with the SEC. The filing -- coming as crude-oil volatility lifts demand for midstream infrastructure -- highlights how the IPO and registration pipeline extends well beyond tech into the physical energy economy underpinning the AI buildout.
Biospecimen Marketplace iSpecimen Files a Form S-1 With the SEC
IPOS-1 filed
Biospecimen Marketplace iSpecimen Files a Form S-1 With the SEC
iSpecimen, which operates an online marketplace connecting medical researchers with human biological specimens, filed a Form S-1 with the SEC. The filing adds a health-data and life-sciences infrastructure name to a 2026 IPO pipeline that has skewed heavily toward AI labs and semiconductors.
Cancer-Immunotherapy Developer Liminatus Pharma Files S-1 to Go Public
IPOS-1 filed
Cancer-Immunotherapy Developer Liminatus Pharma Files S-1 to Go Public
Liminatus Pharma, a clinical-stage biotech developing cancer immunotherapies, filed a Form S-1 with the SEC for an IPO. The filing is a sign of life in the long-dormant biotech IPO market, which has lagged the tech-led reopening.